Trials

A Phase II Multi Center Study of BGB324 in Combination with Pembrolizumab in Patients with Previously Treated Advanced Adenocarcinoma of the Lung

Cancer type: Lung cancer

Phase: II

Principal Investigator: Brunsvig Paal

Country: NO

Keywords: Norway, Oslo, BGB324, AXL-inhibitor

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03184571?term=2016-003609-32&rank=1